Claims that “supercharged biotech rice” yields massively more grain debunked
By Jonathan Matthews and Claire Robinson,
GMWatch
| 08. 14. 2022
Photo by Polina Rytova on Unsplash
Science Magazine recently published a paper in which Chinese scientists reported massive yield gains in rice, thanks to genetic engineering. The journal also promoted the research in a news piece that featured other scientists expressing their amazement at the yield gains achieved. The article suggested the same “genetic tweak” to a single gene could also turbocharge the yields of wheat and other crops.
News of this apparent breakthrough in how to boost global food supplies spread like wildfire on social media and triggered press coverage too. But now a young scientist studying plant breeding has debunked the paper’s claims and dismissed as bogus the whole idea that scientists can “solve” yield through single genes.
“That’s a big number. Amazing”
The “world's leading outlet for cutting-edge research”, as Science styles itself, made sure this GM rice study by a 13-strong team led by crop physiologist Wenbin Zhou of the Chinese Academy of Agricultural Sciences, commanded maximum attention.
In both the Abstract and the longer Structured Abstract that Science published, the yield increases cited for the...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...